We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COP icon
226
ConocoPhillips
COP
$144B
$12.6M 0.08%
106,376
-144,933
-58% -$17.6M
GH icon
227
Guardant Health
GH
$19.3B
$12.5M 0.08%
459,644
+270,594
+143% +$12.4M
TREX icon
228
Trex
TREX
$4.4B
$12.4M 0.08%
293,262
– –
DDOG icon
229
Datadog
DDOG
$95.1B
$12.4M 0.08%
168,835
-613
-0.4% -$47.9K
SRPT icon
230
Sarepta Therapeutics
SRPT
$1.65B
$12.3M 0.08%
+95,144
New +$11M
FTNT icon
231
Fortinet
FTNT
$112B
$12.3M 0.08%
250,925
-139,339
-36% -$7.26M
ORA icon
232
Ormat Technologies
ORA
$5.78B
$12.3M 0.08%
141,818
-35,295
-20% -$3.17M
CMA
233
DELISTED
Comerica
CMA
$12.2M 0.08%
181,838
-65,709
-27% -$4.55M
CCK icon
234
Crown Holdings
CCK
$13B
$11.9M 0.08%
145,238
+7,206
+5% +$574K
NLY icon
235
Annaly Capital Management
NLY
$17.3B
$11.9M 0.08%
565,706
+21,335
+4% +$420K
AFL icon
236
Aflac
AFL
$65.4B
$11.9M 0.08%
164,828
-17,357
-10% -$1.16M
DOV icon
237
Dover
DOV
$26.6B
$11.8M 0.08%
87,248
+53,450
+158% +$7.1M
EBAY icon
238
eBay
EBAY
$51.2B
$11.8M 0.08%
283,725
+27,164
+11% +$1.13M
TRU icon
239
TransUnion
TRU
$16B
$11.8M 0.08%
207,124
+23,353
+13% +$1.37M
CRNC icon
240
Cerence
CRNC
$360M
$11.6M 0.08%
626,578
-539
-0.1% -$9.23K
LH icon
241
Labcorp
LH
$25.2B
$11.5M 0.08%
57,043
-9,783
-15% -$1.91M
COGT icon
242
Cogent Biosciences
COGT
$6.75B
$11.5M 0.08%
997,141
-154,361
-13% -$1.91M
AKRO
243
DELISTED
Akero Therapeutics
AKRO
$11.5M 0.08%
+210,000
New +$9M
KDP icon
244
Keurig Dr Pepper
KDP
$42.5B
$11.5M 0.08%
321,591
+206,759
+180% +$7.75M
KLAC icon
245
KLA
KLAC
$226B
$11.3M 0.08%
300,340
-177,790
-37% -$6.2M
TGT icon
246
Target
TGT
$66.5B
$11.3M 0.08%
75,971
-2,153
-3% -$338K
BPMC
247
DELISTED
Blueprint Medicines
BPMC
$11.3M 0.08%
258,311
– –
LKQ icon
248
LKQ Corp
LKQ
$6.7B
$11.3M 0.08%
210,849
+54,480
+35% +$2.88M
ESGR
249
DELISTED
Enstar Group
ESGR
$11.1M 0.08%
48,203
-13,151
-21% -$2.68M
PCRX icon
250
Pacira BioSciences
PCRX
$1.05B
$11.1M 0.07%
224,901
+45,000
+25% +$2.19M
8 9
10
11 12

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.